CDH5 and breast cancer: Statistical analysis showed that VE‐cadherin was highly expressed in 26 of 36 (72.2%) TP53INP1‐negative breast cancer tissues (P = .044; Figure 1Ba), and there was a negative correlation between TP53INP1 and VE‐cadherin (Pearson analysis r = −.0227, P = .023;Figure S2B).